What is the current AIDS HIV Test Strip market size

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the AIDS HIV Test Strip market

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the AIDS HIV Test Strip market

Increasing awareness and government initiatives are key drivers of the market.

What are the major challenges facing the AIDS HIV Test Strip market

Limited accessibility and high costs are major challenges facing the market.

Which regions are leaders in the AIDS HIV Test Strip market

North America and Europe are regional leaders in the market.

Who are the top companies in the AIDS HIV Test Strip market

Top companies include Roche and Abbott Laboratories.

What are the future opportunities in the AIDS HIV Test Strip market

Emerging markets and technological advancements present future opportunities.

How will technology impact the AIDS HIV Test Strip market

Technological advancements will improve test accuracy and efficiency.

What is the regulatory landscape for the AIDS HIV Test Strip market

Stringent regulations and guidelines govern the market.

What is the future outlook for the AIDS HIV Test Strip market

The market is expected to experience steady growth due to increasing demand.

AIDS (HIV) Test Strip Expansion Opportunities & Forecast Analysis 2033

AIDS (HIV) Test Strip by Application (Online Pharmacy, Hospital, Clinic, Others), by Types (Saliva Test Strip, Urine Test Strip, Blood Test Strip), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $1821 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 87

Forecast Period: 2026 - 2033

Market Size: $1821 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

AIDS (HIV) Test Strip Market Overview

The AIDS (HIV) Test Strip market refers to the industry involved in the development, manufacturing, and distribution of test strips used for the detection of Human Immunodeficiency Virus (HIV). The AIDS (HIV) Test Strip market size is estimated to be around $1.4 billion in 2025, with a growth outlook that is expected to be driven by increasing awareness and screening rates, particularly in developing countries. The market forecast suggests a Compound Annual Growth Rate (CAGR) of 8.5% from 2026 to 2033, driven by industry expansion into new markets and the development of more accurate and convenient testing technologies. Key synonyms for this market include HIV rapid test kits, HIV home test kits, and point-of-care HIV diagnostics.

Loading chart…

The AIDS (HIV) Test Strip market is expected to be shaped by several key forces, including technology shifts towards more accurate and convenient testing methods, regulations that promote the use of HIV testing in various settings, and consumer behavior that drives demand for self-testing and home care solutions. The largest region for the AIDS (HIV) Test Strip market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing awareness and screening rates in countries such as China and India. Overall, the AIDS (HIV) Test Strip market is expected to experience significant growth over the forecast period, driven by a combination of these factors and the ongoing need for effective HIV detection and prevention strategies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.82 billion
Revenue forecast in 2033	3.18 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; AccuQuik Test Kits; AdvaCare Pharma; Mylan HIV Self Test; INS Technologies Inc; OraQuick; Calypte Biomedical Corporation; Xiamen Boson Biotech Co.,Ltd; Wondfo Biotechnology; Core Tests; Tianjin Weide Medical Devices Co.ltd.; Aiweikang Group Co.,Ltd.; Shanghai Kehua Biology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The AIDS (HIV) Test Strip market is experiencing significant transformations, driven by various factors. The market dynamics are intricately linked to the overall AIDS (HIV) Test Strip market size and its growth forecast.

Growth Drivers2 items

Advancements in technology have led to the development of more accurate and user-friendly AIDS (HIV) Test Strip products, increasing their adoption rates among healthcare professionals and individuals alike.

Government initiatives and awareness campaigns have contributed to the growth of the AIDS (HIV) Test Strip market, as they promote the importance of early detection and treatment of HIV/AIDS.

Restraints2 items

The high cost of AIDS (HIV) Test Strip products, particularly in developing regions, hinders their accessibility and affordability for a significant portion of the population, limiting the market's growth potential.

Stringent regulatory requirements and the need for compliance with international standards can pose challenges for manufacturers, affecting the overall AIDS (HIV) Test Strip market size and growth forecast.

Opportunities2 items

The increasing demand for point-of-care diagnostic solutions presents opportunities for manufacturers to develop innovative, portable, and easy-to-use AIDS (HIV) Test Strip products.

Collaborations between manufacturers, research institutions, and healthcare organizations can facilitate the development of more effective AIDS (HIV) Test Strip products, driving growth in the market.

Challenges2 items

The presence of counterfeit AIDS (HIV) Test Strip products in the market poses a significant challenge, as they can lead to inaccurate test results and compromise patient safety.

The AIDS (HIV) Test Strip market is highly competitive, with several established players, making it challenging for new entrants to gain market share and establish their presence.

Market Segmentation

Loading chart…

The AIDS (HIV) Test Strip market can be segmented based on Application, which includes Clinical Diagnosis and Home Testing. The clinical diagnosis segment holds a significant share of the market, as it is widely used in hospitals, clinics, and laboratories for diagnosing HIV. The home testing segment is also growing rapidly due to the increasing demand for self-testing kits. Understanding the AIDS (HIV) Test Strip segmentation is crucial for market players to develop targeted strategies and capitalize on emerging opportunities.

The Types segment of the AIDS (HIV) Test Strip market includes Rapid Test and Laboratory Test. Rapid tests are further sub-segmented into Lateral Flow Assays and Dipstick Tests, while laboratory tests include Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot. Each subtype has its own set of advantages and disadvantages, and market players need to understand these differences to develop effective products and marketing strategies. The market taxonomy of the AIDS (HIV) Test Strip market is complex, with each segment contributing to the overall market size.

AIDS (HIV) Test Strip Segmentation Breakdown9 items

Application

Online Pharmacy

Hospital

Clinic

Others

Types

Saliva Test Strip

Urine Test Strip

Blood Test Strip

Regional Insights

Loading chart…

The AIDS (HIV) Test Strip market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market, driven by high adoption rates, favourable policies, and significant investments in healthcare infrastructure. The fastest-growing region is expected to be Asia Pacific, driven by increasing awareness, expanding healthcare infrastructure, and growing demand for AIDS (HIV) test strips.

In North America, key drivers include established healthcare infrastructure, high awareness about HIV/AIDS, and government initiatives to promote AIDS (HIV) test strip market growth. In Europe, drivers include mature ecosystems, strong regulatory frameworks, and increased focus on preventive care. Asia Pacific is driven by rapidly developing healthcare infrastructure, growing demographics, and increasing investments in AIDS (HIV) test strip market. Latin America and Middle East & Africa are driven by growing awareness, expanding healthcare access, and improving ecosystem maturity.

The regional forecast indicates that the AIDS (HIV) Test Strip market will experience significant growth in the coming years, with each region contributing to the overall market growth. Understanding the regional dynamics and key drivers is crucial for stakeholders to make informed decisions and capitalize on the growth opportunities in the AIDS (HIV) test strip market.

Competitive Landscape

The AIDS (HIV) Test Strip market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The AIDS (HIV) Test Strip competitive landscape is characterized by high competition, with companies focusing on differentiation through quality, reliability, and customer service. Global players have a strong presence, but local companies are also gaining traction, particularly in emerging markets.

Companies in the AIDS (HIV) Test Strip market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and profitability.

Abbott: regional expansion

AccuQuik Test Kits: premium pricing

AdvaCare Pharma: OEM tie-ups

Mylan HIV Self Test: innovation pipeline

INS Technologies Inc: local manufacturing

OraQuick: vertical integration

Key AIDS (HIV) Test Strip Companies13 items

Abbott

AccuQuik Test Kits

AdvaCare Pharma

Mylan HIV Self Test

INS Technologies Inc

OraQuick

Calypte Biomedical Corporation

Xiamen Boson Biotech Co.,Ltd

Wondfo Biotechnology

Core Tests

Tianjin Weide Medical Devices Co.ltd.

Aiweikang Group Co.,Ltd.

Shanghai Kehua Biology

Market Ecosystem

The AIDS (HIV) Test Strip ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of test strips, with each participant contributing to the overall value chain. The ecosystem boundaries are defined by the flow of goods, services, and information from raw material suppliers to end users, with various intermediaries playing crucial roles in the process.

Raw material suppliers — providing essential components

OEMs / manufacturers — producing test strips

Distributors / channel partners — delivering products to markets

Service providers / after-sales — offering support and maintenance

End users / buyers — utilizing test strips for diagnosis

Regulators/standards bodies — establishing guidelines and approvals

Data/analytics providers — providing insights for improvement

In the AIDS (HIV) Test Strip ecosystem, value flows through the interactions among participants, with control points influencing adoption, such as regulatory approvals and reimbursement policies. Dependency risks arise from input constraints, standards, and approvals, while switching costs, partnerships, and interoperability requirements can impact the ecosystem's dynamics. A thorough value chain analysis is necessary to understand these complexities and identify opportunities for growth and improvement.

Recent Industry Insights

The AIDS (HIV) Test Strip industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as the collaboration between leading diagnostic companies and research institutions, have accelerated the development of innovative testing solutions. Furthermore, strategic mergers and acquisitions have enabled companies to expand their product portfolios and strengthen their market presence. Recent product launches, including rapid diagnostic kits and point-of-care testing devices, have improved the accessibility and accuracy of HIV testing. Additionally, regulatory changes have emphasized the importance of quality control and standardization in the industry, driving companies to enhance their manufacturing processes and quality assurance protocols. These developments have contributed to the growth of the AIDS (HIV) Test Strip market, with a focus on increasing testing rates and early detection.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the AIDS (HIV) Test Strip market outlook. The market attractiveness is moderate, driven by increasing awareness and demand for point-of-care diagnostic solutions. Competitive intensity is high, with several established players and new entrants vying for market share. The long-term outlook is positive, with growing demand from emerging economies and advancements in technology.

The innovation landscape is evolving, with a focus on rapid and accurate testing. Demand-supply balance is expected to be stable, with manufacturers ramping up production to meet growing demand. Key risk factors include regulatory changes and supply chain disruptions. Overall, the AIDS (HIV) Test Strip market is expected to experience steady growth, driven by increasing demand and advancements in technology.

11 items

1. Executive Summary

2. AIDS (HIV) Test Strip Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global AIDS (HIV) Test Strip Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global AIDS (HIV) Test Strip Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Online Pharmacy

6.1.2. Hospital

6.1.3. Clinic

6.1.4. Others

6.2. Global AIDS (HIV) Test Strip Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Saliva Test Strip

6.2.2. Urine Test Strip

6.2.3. Blood Test Strip

6.3. Global AIDS (HIV) Test Strip Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global AIDS (HIV) Test Strip Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global AIDS (HIV) Test Strip Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global AIDS (HIV) Test Strip Market Competition by Key Manufacturers

8.1. Global AIDS (HIV) Test Strip Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global AIDS (HIV) Test Strip: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Abbott

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. AccuQuik Test Kits

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. AdvaCare Pharma

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Mylan HIV Self Test

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. INS Technologies Inc

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. OraQuick

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Calypte Biomedical Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Xiamen Boson Biotech Co.,Ltd

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Wondfo Biotechnology

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Core Tests

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Tianjin Weide Medical Devices Co.ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Aiweikang Group Co.,Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Shanghai Kehua Biology

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global AIDS (HIV) Test Strip Market

Figure 4: Global AIDS (HIV) Test Strip Market: Drivers

Figure 5: Global AIDS (HIV) Test Strip Market: Challenges

Figure 6: Global AIDS (HIV) Test Strip Market: Trends

Figure 7: Global AIDS (HIV) Test Strip Market: Opportunity

Figure 8: Global AIDS (HIV) Test Strip Market: Restraint

Figure 9: Global AIDS (HIV) Test Strip Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global AIDS (HIV) Test Strip Market Value (USD Million) By Region

Figure 15: Global AIDS (HIV) Test Strip Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global AIDS (HIV) Test Strip Market Value (USD Million) By Region

Figure 23: Global AIDS (HIV) Test Strip Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global AIDS (HIV) Test Strip Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global AIDS (HIV) Test Strip Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global AIDS (HIV) Test Strip Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global AIDS (HIV) Test Strip Market Value (USD Million) By Region

Table 10: Global AIDS (HIV) Test Strip Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global AIDS (HIV) Test Strip Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global AIDS (HIV) Test Strip Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global AIDS (HIV) Test Strip Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Abbott Basic Information And Sales Area

Table 31: Abbott. Products Portfolio

Table 32: AccuQuik Test Kits Basic Information And Sales Area

Table 33: AccuQuik Test Kits. Products Portfolio

Table 34: AdvaCare Pharma Basic Information And Sales Area

Table 35: AdvaCare Pharma. Products Portfolio

Table 36: Mylan HIV Self Test Basic Information And Sales Area

Table 37: Mylan HIV Self Test. Products Portfolio

Table 38: INS Technologies Inc Basic Information And Sales Area

Table 39: INS Technologies Inc. Products Portfolio

Table 40: OraQuick Basic Information And Sales Area

Table 41: OraQuick. Products Portfolio

Table 42: Calypte Biomedical Corporation Basic Information And Sales Area

Table 43: Calypte Biomedical Corporation. Products Portfolio

Table 44: Xiamen Boson Biotech Co.,Ltd Basic Information And Sales Area

Table 45: Xiamen Boson Biotech Co.,Ltd. Products Portfolio

Table 46: Wondfo Biotechnology Basic Information And Sales Area

Table 47: Wondfo Biotechnology. Products Portfolio

Table 48: Core Tests Basic Information And Sales Area

Table 49: Core Tests. Products Portfolio

Table 50: Tianjin Weide Medical Devices Co.ltd. Basic Information And Sales Area

Table 51: Tianjin Weide Medical Devices Co.ltd.. Products Portfolio

Table 52: Aiweikang Group Co.,Ltd. Basic Information And Sales Area

Table 53: Aiweikang Group Co.,Ltd.. Products Portfolio

Table 54: Shanghai Kehua Biology Basic Information And Sales Area

Table 55: Shanghai Kehua Biology. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global AIDS (HIV) Test Strip Market Value (USD Million) By Region

Table 61: Global AIDS (HIV) Test Strip Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

AIDS (HIV) Test Strip Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.82 billion
Revenue forecast in 2033	3.18 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; AccuQuik Test Kits; AdvaCare Pharma; Mylan HIV Self Test; INS Technologies Inc; OraQuick; Calypte Biomedical Corporation; Xiamen Boson Biotech Co.,Ltd; Wondfo Biotechnology; Core Tests; Tianjin Weide Medical Devices Co.ltd.; Aiweikang Group Co.,Ltd.; Shanghai Kehua Biology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Government initiatives and awareness campaigns have contributed to the growth of the AIDS (HIV) Test Strip market, as they promote the importance of early detection and treatment of HIV/AIDS.

Restraints2 items

Opportunities2 items

The increasing demand for point-of-care diagnostic solutions presents opportunities for manufacturers to develop innovative, portable, and easy-to-use AIDS (HIV) Test Strip products.

Challenges2 items

The presence of counterfeit AIDS (HIV) Test Strip products in the market poses a significant challenge, as they can lead to inaccurate test results and compromise patient safety.

The AIDS (HIV) Test Strip market is highly competitive, with several established players, making it challenging for new entrants to gain market share and establish their presence.

Market Segmentation

Loading chart…

AIDS (HIV) Test Strip Segmentation Breakdown9 items

Application

Online Pharmacy

Hospital

Clinic

Others

Types

Saliva Test Strip

Urine Test Strip

Blood Test Strip

Regional Insights

Loading chart…

Competitive Landscape

Abbott: regional expansion

AccuQuik Test Kits: premium pricing

AdvaCare Pharma: OEM tie-ups

Mylan HIV Self Test: innovation pipeline

INS Technologies Inc: local manufacturing

OraQuick: vertical integration

Key AIDS (HIV) Test Strip Companies13 items

Abbott

AccuQuik Test Kits

AdvaCare Pharma

Mylan HIV Self Test

INS Technologies Inc

OraQuick

Calypte Biomedical Corporation

Xiamen Boson Biotech Co.,Ltd

Wondfo Biotechnology

Core Tests

Tianjin Weide Medical Devices Co.ltd.

Aiweikang Group Co.,Ltd.

Shanghai Kehua Biology

Market Ecosystem

Raw material suppliers — providing essential components

OEMs / manufacturers — producing test strips

Distributors / channel partners — delivering products to markets

Service providers / after-sales — offering support and maintenance

End users / buyers — utilizing test strips for diagnosis

Regulators/standards bodies — establishing guidelines and approvals

Data/analytics providers — providing insights for improvement

Recent Industry Insights

Analyst Overview

Table of Contents